je.st
news
Tag: in
Alstom gets approval for operation of Coradia Lint in Poland
2016-05-17 01:00:00| Railway Technology
French multinational firm Alstom has received approval for its Coradia Lint 41 regional trains on the rail network of Poland.
Tags: in
operation
approval
poland
Guilty as charged: why are passengers paying an extra 5.4bn in airport fees?
2016-05-17 01:00:00| Airport Technology
New data commissioned by lobby group Airlines for Europe (A4E) reveals that charges at Europes 21 largest airports have increased 80% over the past decade at a cost of 5.4bn to passengers. Julian Turner talks to Aage Dünhaupt of A4E about the cam
A fully stocked line of medicine usually provides a big portion of veterinarian income, but it's not the only way to bring in profits
2016-05-16 22:34:00| Beef
Veterinarians are changing up the way they distribute drugs and supplies. Find out what this could mean for you. read more
23/06/2016 - Catering & Hospitality SIG - 11 Key Trends you Need to Know in the UK Foodservice Market
2016-05-16 17:53:17| BIFM Events
New KEYTRUDA (pembrolizumab) Data at 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data in Melanoma and Updated Overall Survival Data in Non-Small Cell Lung Cancer As Well As Updated Findings in Head and Neck Cancer
2016-05-16 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Data at ASCO Evaluates KEYTRUDA As Single Agent and in Novel Combinations in More Than 15 Different Cancers, Including Several New Tumors KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new and updated data investigating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in more than 15 types of cancer will be presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 3 7, 2016. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558Kim Hamilton, (908) 740-1863orInvestor:Teri Loxam, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [487] [488] [489] [490] [491] [492] [493] [494] [495] [496] [497] [498] [499] [500] [501] [502] [503] [504] [505] [506] next »